VPTDF (VentriPoint Diagnostics) Beginning Cash Position: $0.05 Mil (As of Dec. 2025)


What is VentriPoint Diagnostics Beginning Cash Position?

VentriPoint Diagnostics VPTDF +13.11% Beginning Cash Position is $0.05 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

VentriPoint Diagnostics's Beginning Cash Position for the quarter that ended in Dec. 2025 was $0.05 Mil.

VentriPoint Diagnostics's quarterly Beginning Cash Position declined from Jun. 2025 ($0.26 Mil) to Sep. 2025 ($0.18 Mil) and declined from Sep. 2025 ($0.18 Mil) to Dec. 2025 ($0.05 Mil).

VentriPoint Diagnostics's annual Beginning Cash Position declined from Dec. 2023 ($3.87 Mil) to Dec. 2024 ($0.91 Mil) and declined from Dec. 2024 ($0.91 Mil) to Dec. 2025 ($0.04 Mil).

VentriPoint Diagnostics Beginning Cash Position Related Terms

VentriPoint Diagnostics Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for VentriPoint Diagnostics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VentriPoint Diagnostics Beginning Cash Position Chart

VentriPoint Diagnostics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 6.82 3.87 0.91 0.04

VentriPoint Diagnostics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.04 0.26 0.18 0.05

VentriPoint Diagnostics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.05 Mil mean?
VentriPoint Diagnostics (VPTDF) has a Beginning Cash Position of $0.05 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on VentriPoint Diagnostics and its competitors.
Is VentriPoint Diagnostics' Beginning Cash Position too high?
VentriPoint Diagnostics' current Beginning Cash Position is $0.05 Mil.
How does VentriPoint Diagnostics' Beginning Cash Position compare to ABT and SYK?
VentriPoint Diagnostics' Beginning Cash Position of $0.05 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on VentriPoint Diagnostics and its competitors. VentriPoint Diagnostics's current Beginning Cash Position is $0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VentriPoint Diagnostics stock overvalued right now?
VentriPoint Diagnostics (VPTDF) has a current Beginning Cash Position of $0.05 Mil. The current Beginning Cash Position is $0.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For VentriPoint Diagnostics (VPTDF), the current Beginning Cash Position is $0.05 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VentriPoint Diagnostics Business Description

Other Exchanges VPT:Canada
Address 18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.